# Advanced Goal-Directed Impedancemetry Strategy for Lung Resection Surgery

> **NCT06156943** · NA · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 722 (estimated)

## Conditions studied

- High-risk Lung Resection Surgery

## Interventions

- **PROCEDURE:** individualized goal-directed fluid therapy by Starling device
- **PROCEDURE:** group managed by standard of care

## Key facts

- **NCT ID:** NCT06156943
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-12
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 722 (ESTIMATED)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06156943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06156943, "Advanced Goal-Directed Impedancemetry Strategy for Lung Resection Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06156943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*